Press

GLOBAL NEONATAL AND PERINATAL PRODUCT MARKETS SET TO GROW TO OVER $1.5 BILLION BY 2013

HUNTINGTON BEACH, Calif.-Oct 23, 2008--(BUSINESS WIRE)--According to a new Life Science Intelligence (LSI) report, 2008 Global Markets for Neonatal/Perinatal Monitoring and Treatment Products: U.S., Europe, Rest of World, developing markets for neonatal and perinatal products outside of the U.S. and Europe will experience substantial growth, from $313 million in 2008 to $451 million in 2013.  In addition, the report concludes that significant worldwide growth will occur in several product areas, particularly in the infant ventilation and warming segments. 

Growth in Asia-Pacific and other international markets will be driven by expanding populations and increasing birth rates, greater demand for these products, and the growing availability of low-cost or locally manufactured technologies.  Developing countries account for the vast majority of annual births and preterm infants, which are at risk for developing conditions requiring ventilation, warming therapy, jaundice management, and neonatal monitoring.  Driven by a growing middle class, demand is increasing for these products, which are well-established in the developed markets of the U.S., Western Europe, and Japan.  The growing availability of low-cost and locally manufactured products will continue to drive sales of new units in these countries. 

While the larger U.S. and European markets will not grow at the same pace as Asia-Pacific and Rest of World (ROW) markets through 2013, the substantial revenues that these regions represent will be driven by replacement technologies and accessories.  Furthermore, hospitals will continue to prefer devices that offer multiple functions.  In infant ventilation, sales will increasingly shift towards comprehensive units capable of treating a full range of patients, including neonatal, pediatric, and adult patients.  Hybrid warming devices that can be configured as either open warmers or closed incubators will also be preferred.  Specialty products, such as high-frequency ventilators, will also see strong sales growth through 2013.  Homecare will represent a growing source for sales of monitoring and jaundice management products.

Immediate access to the Table of Contents for this report is available at:  lifescienceintelligence.com/market-reports-page.php?id=LSI-WW081PTM

2008 Global Markets for Neonatal/Perinatal Monitoring and Treatment Products:  U.S., Europe, Rest of World covers infant ventilation, warming, jaundice management, and monitoring products in U.S., Europe, Asia-Pacific, and ROW markets.  Featured companies include Atom Medical, Draeger Medical (DRW3.F), Fisher & Paykel Healthcare (FPH.NZ), GE Healthcare (GE), Maquet/Getinge (GTN.F), Respironics/Philips Healthcare (PHG), Spacelabs Healthcare/OSI Systems (OSIS), and Viasys/Cardinal Health (CAH).

About Life Science Intelligence (LSI)®
LSI delivers high-quality market data and information to medical technology executives, entrepreneurs, and investors.  LSI produces the EMT (Emerging Medical Technologies)® Database, medtech market reports, and provides global custom research services, including market assessments and physician surveys.  In addition, LSI partners with top-tier information companies such as Health Research International (HRI) and Windhover/Medtech Insight to distribute their high-end information products.  www.LSintelligence.com.

Contact:
Life Science Intelligence, Huntington Beach
Scott Pantel, 714 847 3540
scott@LSintelligence.com
www.lsintelligence.com
www.emergingmedicaltechnologies.com